Primary Site >> Liver Cancer

Gene >> ACSM3

Journal: Anticancer Res. 1993 Sep-Oct;13(5A):1341-56.
Title: Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy.
Author: Pascale, R M|Simile, M M|Feo, F
PMID: 8239505
Journal: Hepatology. 1999 May;29(5):1471-8.
Title: Differential effect of thioacetamide on hepatic methionine adenosyltransferase expression in the rat.
Author: Huang, Z Z|Mato, J M|Kanel, G|Lu, S C
PMID: 10216131
Journal: Cell Oncol (Dordr). 2017 Jun;40(3):219-233.
Title: Integrative transcriptome analysis of liver cancer profiles identifies upstream regulators and clinical significance of ACSM3 gene expression.
Author: Gopal, Ramani|Selvarasu, Karthikeyan|Pandian, Ponmathi Panneer|Ganesan, Kumaresan
PMID: 28390038
Journal: Am J Cancer Res. 2017 Mar 1;7(3):543-553. eCollection 2017.
Title: Downregulation of ACSM3 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma.
Author: Ruan, Hao-Yu|Yang, Chen|Tao, Xue-Mei|He, Jia|Wang, Ting|Wang, Hui|Wang, Cun|Jin, Guang-Zhi|Jin, Hao-Jie|Qin, Wen-Xin
PMID: 28401010